Revenue: The sum of all revenue fields included for a company's operating activities.
Baudax Bio, Inc. (BXRXQ) had Revenue of $1.27M for the most recently reported fiscal year, ending 2022-12-31.
Income Statement Financials | |
Revenue |
$1.27M |
$-58.80M |
|
$7.01M |
|
$-5.74M |
|
$58.08M |
|
$-56.81M |
|
$-1.98M |
|
$-58.80M |
|
$-58.80M |
|
$-58.80M |
|
$-58.80M |
|
$-58.80M |
|
$-58.80M |
|
$-56.81M |
|
$-54.65M |
|
0.33M |
|
0.33M |
|
$-177.30 |
|
$-177.30 |
|
Balance Sheet Financials | |
$6.35M |
|
$0.70M |
|
$3.69M |
|
$10.03M |
|
$21.46M |
|
$1.52M |
|
$12.81M |
|
$34.27M |
|
$-24.24M |
|
$-26.37M |
|
$-24.24M |
|
1.62M |
|
Cash Flow Statement Financials | |
$-27.79M |
|
$-0.02M |
|
$17.18M |
|
$15.89M |
|
$5.26M |
|
$-10.63M |
|
$1.40M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.30 |
|
-- |
|
-- |
|
-0.07 |
|
-0.29 |
|
-452.32% |
|
-4476.99% |
|
-4476.99% |
|
-4306.62% |
|
-4633.18% |
|
-4633.18% |
|
$-27.81M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
3.79 |
|
96.36 |
|
242.53% |
|
222.97% |
|
-586.07% |
|
258.75% |
|
$-14.93 |
|
$-83.77 |
|
$-83.71 |